PICTURE OF FASTING BLOOD GLUCOSE LEVELS IN HYPERTENSION PATIENTS AT TOTO KABILA REGIONAL GENERAL
DOI:
https://doi.org/10.47918/jhts.v7i1.2517Keywords:
Hypertension, Fasting Blood Glucose, Toto Kabila Regional HospitalAbstract
Hypertension is a chronic condition that significantly increases the risk of cardiovascular and metabolic complications. Impaired blood glucose regulation is a common complication, making fasting blood glucose (FBG) monitoring essential for early detection of metabolic disorders, particularly diabetes mellitus. Objective: This study aims to describe the profile of FBG levels among hypertensive patients at Toto Kabila Regional General Hospital. Methods: A quantitative descriptive study with a cross-sectional approach was conducted between July and August 2025. A sample of 27 hypertensive patients was selected using a purposive sampling technique. FBG levels were measured using the Point of Care Testing (POCT) method. Results: The findings revealed that out of 27 patients, 10 individuals (37%) had normal FBG levels (70–126 mg/dL), while 17 individuals (63%) exhibited abnormal levels (<70 or >126 mg/dL). The mean FBG value was 228.52 mg/dL, indicating a high prevalence of hyperglycemia in the study population. Conclusion: The majority of hypertensive patients at Toto Kabila Regional General Hospital have abnormal fasting blood glucose levels. These results provide critical baseline data for healthcare providers to implement early prevention and management strategies for metabolic complications in hypertensive patients.
References
[1] W. Azizah, U. Hasanah, and A. T. Pakarti, “Application of Slow Deep Breathing to Blood Pressure in Hypertension Patients,” J. Cendikia Muda, vol. 2, no. 4, pp. 607–616, 2022.
[2] F. S. Rad, S. Oveisi, H. R. Javadi, A. Barikani, and M. Sofiabadi, “Association between hypertension and insulin resistance in non-diabetic adult populations: A community-based study from the Iran,” Arter. Hypertens., vol. 24, no. 4, pp. 159–166, 2020, doi: 10.5603/AH.A2020.0020.
[3] B. Wang, Y. Yang, and X. Li, “Interaction of Hypertension and Insulin Resistance Exacerbates the Occurrence of Diabetes Mellitus in Healthy Individuals,” J. Diabetes Res., vol. 2022, 2022, doi: 10.1155/2022/9289812.
[4] Z. Guo et al., “Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018,” Lipids Heal. Dis. , vol. 24, no. 1, 2025, doi: 10.1186/s12944-025-02492-y.
[5] D. Parameswari, Kadek, and Hardinata, “The relationship between fasting blood glucose and hypertension in type 2 diabetes mellitus patients at North Lombok District Hospital,” 2023.
[6] Y. Si et al., “Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study,” Diabetes Ther., vol. 12, no. 4, pp. 1117–1128, 2021, doi: 10.1007/s13300-021-01019-9.
[7] M. Azam, F. N. Hidayati, A. I. Fibriana, U. Bahrudin, and S. M. Aljunid, “Isolated Systolic Hypertension among Diabetes Mellitus Subjects; a national cross-sectional study in Indonesia,” Kemas, vol. 19, no. 1, pp. 53–64, 2023, doi: 10.15294/kemas.v19i1.40548.
[8] S. Sharma, R. Gupta, and A. Kumar, “Vascular aging and hypertension: The role of arterial stiffness in older adults,” J. Hypertens. Cardiovasc. Res., vol. 42, no. 2, pp. 115–123, 2023.
[9] M. of H. of the R. of Indonesia, “Indonesian Health Survey Report 2023: Prevalence of Non-Communicable Diseases in Indonesia,” Health Research and Development Agency, Ministry of Health of the Republic of Indonesia, Jakarta, 2023.
[10] R. Rahman, P. Anindita, and A. Wibowo, “Insulin resistance in elderly hypertensive patients: implications for glycemic control,” Indones. J. Med., vol. 8, no. 1, pp. 55–63, 2023.
[11] D. A. Putri, M. Sari, and H. Nugroho, “Prevalence of hyperglycemia in hypertensive patients based on age and gender,” Indones. Nurs. J., vol. 24, no. 3, pp. 167–175, 2021.
[12] N. K. A. Sujani and N. K. Ayu, “Description of fasting blood glucose levels in elderly patients with hypertension at the Selat Community Health Center, Karangasem,” Med. Lab. J., vol. 12, no. 1, pp. 22–30, 2024.
[13] N. L. Nofisah, “Blood glucose and risk factors for hypertension.” Repository of UIN Syarif Hidayatullah Jakarta, 2023.
[14] F. Husaini and T. R. Fonna, “Hypertension and complications accompanying hypertension,” J. Med. Nusant., vol. 2, no. 3, pp. 45–52, 2025.
[15] A. C. Guyton and J. E. Hall, Textbook of Medical Physiology, 14th ed. Philadelphia: Elsevier, 2021.
[16] T. O. Akande, J. O. Adeleye, and S. Kadiri, “Insulin resistance in Nigerians with essential hypertension,” Afr. Health Sci., vol. 13, no. 3, pp. 655–660, 2013, doi: 10.4314/ahs.v13i3.19.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Nirmawati Masalam, Erfan AR Lainjong, Marlia
This work is licensed under a Creative Commons Attribution 4.0 International License.
